|

|

|
|

|
ANTIBODIES TO
CHD PROTEINS
The CHD family of proteins
appears to be primarily involved in the regulation of developmental gene
expression and heterochromatin formation. There are nine members of the CHD
family of proteins (CHD1-9). The CHD family members possess three common
structural and functional domains: a chromodomain (chromatin organization
modifier), an SNF2-like helicase/ATPase domain, and a C-terminal
DNA-binding domain. The chromodomain functions to recognize and bind
nucleosomes while the SNF2-like helicase/ATP domain provides the energy
required for histone displacement and nucleosomal sliding for remodeling.
The DNA-binding domain is more divergent among the CHD family members and
may partially function to promote sequence specific interactions with DNA.
Despite their structural similarity, the functions of the CHD family
members are diverse. Functional diversity is likely imparted by the divergence
in the DNA binding domain, as well as differences in binding partners and
expression patterns of the CHD family members. Continued study of the
functional contribution of each CHD family member to chromatin remodeling
will further our understanding of how appropriate gene activation and
repression is achieved in the developing organism.
|

|

Detection of Human and Mouse
CHD4/Mi2 beta by Western Blot (h&m) and Immunoprecipitation (h).
Samples: Whole cell lysate from HeLa (5, 15
and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 mcg) and
mouse NIH3T3 (M; 50 mcg) cells. Antibodies:
Affinity purified rabbit anti-CHD4/Mi2 beta antibody A301-082A
used for WB at 0.04 mcg/ml (A) and 0.1 mcg/ml (B) and used for IP at 3
mcg/mg lysate. CHD4/Mi2 beta was also immunoprecipitated by rabbit
anti-CHD4/Mi2 beta antibodies A301-081A
and A301-083A,
which recognize other epitopes. For blotting immunoprecipitated
CHD4/Mi2 beta, ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection: Chemiluminescence
with exposure times of 10 seconds (A and B).
|
|

|
NEW POLYCLONAL ANTIBODIES
|
ABRO
|
Applications: WB, IP
|
|
BRF1
|
Applications: WB, IP
|
|
CHD1
|
Applications: WB, IP
|
|
CHD3
|
Applications: WB, IP
|
|
CHD6
|
Applications: WB, IP
|
|
CHD7
|
Applications: WB, IP
|
|
CHD8
|
Applications: WB, IP
|
|
CHD9/CReMM
|
Applications: WB, IP
|
|
CSTF50
|
Applications: WB, IP
|
|
FANCI
|
Applications: WB, IP
|
|
GTF3C2/TFIIIC110
|
Applications: WB, IP
|
|
GTF3C3/TFIIIC102
|
Applications: WB, IP
|
|
GTF3C4/TFIIIC90
|
Applications: WB, IP
|
|
GTF3C5/TFIIIC63
|
Applications: WB, IP
|
|
ILK
|
Applications: WB, IP
|
|
INT5
|
Applications: WB, IP
|
|
p16INK4a
|
Applications: WB, IP
|
|
PAK1
|
Applications: WB, IP
|
|
PAK2
|
Applications: WB, IP
|
|
PALB2
|
Applications: WB, IP
|
|
PolD3/p66
|
Applications: WB, IP
|
|
PolE3/p17
|
Applications: WB, IP
|
|
PolH
|
Applications: WB, IP
|
|
RBBP4/RbAp48
|
Applications: WB, IP
|
|
RBM13
|
Applications: WB, IP
|
|
RBM26
|
Applications: WB, IP
|
|
RBM27
|
Applications: WB, IP
|
|
ROBO1
|
Applications: WB, IP
|
|
SGO2
|
Applications: WB, IP
|
|
SPTAN1/Alpha
II-spectrin
|
Applications: WB, IP
|
|
TBP
|
Applications: WB
|
|
TLK1
|
Applications: WB, IP
|
|
TLK2
|
Applications: WB, IP
|
|
TRIM3/BERP
|
Applications: IP
|
|
TRIM29/ATDC
|
Applications: IP
|
|
TRIM56
|
Applications: WB, IP
|
|
ZNHIT3/TRIP3
|
Applications: WB, IP
|
|

|

Detection of Human CHD9/CReMM
by Western Blot and Immunoprecipitation. Samples: Whole cell lysate from HeLa (5, 15 and 50 mcg
for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 mcg) cells. Antibodies: Affinity purified rabbit
anti-CHD9/CReMM antibody A301-226A
used for WB at 0.4 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg
lysate. For blotting immunoprecipitated CHD9/CReMM, ReliaBLOT®
Reagents and Procedures (Cat. No. WB120)
were used. Detection: Chemiluminescence
with exposure times of 30 seconds (A and B).

Detection of Human CHD1 by Western
Blot and Immunoprecipitation. Samples:
Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of
IP loaded) and 293T (T; 50 mcg) cells. Antibodies: Affinity purified rabbit anti-CHD1 antibody A301-218A
used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg
lysate. CHD1 was also immunoprecipitated by rabbit anti-CHD1 antibody
A301-217A,
which recognizes an upstream epitope. For blotting immunoprecipitated
CHD1, ReliaBLOT® Reagents and Procedures (Cat. No. WB120)
were used. Detection: Chemiluminescence
with exposure times of 3 seconds (A) and 10 seconds (B).
ReliaBLOT is a registered trademark of Bethyl Laboratories, Inc.
|
|

|
NEW
IHC ANTIBODIES
RECENT
CITATIONS...
4E-BP1 and eIF4G
Amino acids augment muscle protein synthesis in neonatal pigs during acute
endotoxemia by stimulating mTOR-dependent translation initiation
Renán A. Orellana, Asumthia Jeyapalan, Jeffery Escobar, Jason W. Frank,
Hanh V. Nguyen, Agus Suryawan, and Teresa A. Davis
Am J Physiol Endocrinol Metab, Nov 2007; 293: E1416 - E1425.
H2AX
Developmental Pluripotency-associated 4 (DPPA4) Localized in Active
Chromatin Inhibits Mouse Embryonic Stem Cell Differentiation into a
Primitive Ectoderm Lineage
Hisaharu Masaki, Tomohiro Nishida, Shigetaka Kitajima, Kinji Asahina, and
Hirobumi Teraoka
J. Biol. Chem., Nov 2007; 282: 33034 - 33042.
|
|
|
A.
|
B.
|
|
C. 
|
D. 
|
A. Detection of Human XRN2 by IHC.
Sample:
FFPE section of human breast carcinoma. Antibody:
Affinity purified rabbit anti-XRN2 (Cat. No. IHC-00223)
used at a dilution of 1:250.Detection:
DAB staining using IHC Accessory Kit (Cat. No. IHC-101).
B. Detection of Human Filamin A by IHC.
Sample: FFPE
section of human colon carcinoma. Antibody:
Affinity purified rabbit anti-Filamin A (Cat. No. IHC-00225)
used at a dilution of 1:250.Detection:
DAB staining using IHC Accessory Kit (Cat. No. IHC-101).
C. Detection of Human DNA Ligase 1 by
IHC.
Sample: FFPE section
of human colon carcinoma. Antibody:
Affinity purified rabbit anti-DNA Ligase 1 (Cat. No. IHC-00226)
used at a dilution of 1:500.Detection:
DAB staining using IHC Accessory Kit (Cat. No. IHC-101).
D. Detection of Human CPSF73 by IHC.
Sample: FFPE
section of human prostate carcinoma. Antibody:
Affinity purified rabbit anti-CPSF73(Cat. No. IHC-00229)
used at a dilution of 1:250.Detection:
DAB staining using IHC Accessory Kit (Cat. No. IHC-101).
|
|
|
|